Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11833226 Recombinant adeno-associated vectors for targeted treatment
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
February 11, 2020
0
Date of Patent
December 5, 2023
0
Patent Application Number
16787980
0
Patent Citations
US Patent 9623120 Recombinant adeno-associated vectors for targeted treatment
0
US Patent 9783825 Recombinant adeno-associated vectors for targeted treatment
0
US Patent 9777291 Recombinant adeno-associated vectors for targeted treatment
0
US Patent 9803218 Recombinant adeno-associated vectors for targeted treatment
0
US Patent 8628966 CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
0
US Patent 8927514 Recombinant adeno-associated vectors for targeted treatment
0
Patent Inventor Names
Laura Jane Smith
0
Kamehameha Wong
0
Saswati Chatterjee
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11833226
0
Patent Primary Examiner
Marcia S Noble
0
Find more entities like US Patent 11833226 Recombinant adeno-associated vectors for targeted treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE